Molecular profiling of allergen components moves closer to explaining the mechanisms of development of different molecular endotypes and clinical phenotypes of AD and provides biomarkers of disease severity, autoimmune IgE responses, and therapeutic response, improving understanding of atopic dermatitis endotypes and treatment outcomes. Here, IGHE is linked to Alzheimer disease.